Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.

@article{Lang2010ImpactOI,
  title={Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus-infected patients: a case-control study nested within the French Hospital Database on HIV ANRS cohort CO4.},
  author={Sylvie Lang and Murielle Mary-Krause and Laurent Cotte and Jacques M. Gilquin and Marialuisa Partisani and Anne Simon and Franck Boccara and Dominique Costagliola},
  journal={Archives of internal medicine},
  year={2010},
  volume={170 14},
  pages={1228-38}
}
BACKGROUND The role of exposure to specific antiretroviral drugs on risk of myocardial infarction in human immunodeficiency virus (HIV)-infected patients is debated in the literature. METHODS To assess whether we confirmed the association between exposure to abacavir and risk of myocardial infarction (MI) and to estimate the impact of exposure to other nucleoside reverse transcriptase inhibitors (NRTIs), protease inhibitors (PIs), and non-NRTIs on risk of MI, we conducted a case-control study… CONTINUE READING